Ajooni Biotech Share Price Today

Ajooni Biotech website updated per SEBI LODR Regulation 46

Ajooni Biotech Limited confirmed its website is updated and functional in compliance with Regulation 46 of the SEBI (LODR) Regulations, 2015. The official website is www.ajoonibiotech.com. Managing Director Jasjot Singh submitted the undertaking to the National Stock Exchange on July 14, 2026.

Ajooni Biotech to hold 16th AGM on July 29, 2026

Ajooni Biotech has announced its 16th Annual General Meeting for July 29, 2026, via video conferencing. The agenda includes adopting audited financial statements for FY26 and re-appointing a director. Special resolutions propose increasing authorised share capital from ₹50 crore to ₹70 crore and issuing up to 90,00,000 shares to promoter Healthy Biosciences Limited at ₹4.30 per share to raise ₹3.87 crore for infrastructure development.

Ajooni Biotech closes trading window from July 01 for Q1FY26 results

Ajooni Biotech Limited has closed its trading window effective July 01, 2026, for all officers and designated employees, including directors, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The restriction will remain in force until 48 hours after the company announces its unaudited financial results for the quarter ended June 30, 2026 to the stock exchange.

Ajooni Biotech FY26 net profit rises 28% on revenue surge

Ajooni Biotech reported a 28.2% increase in net profit to ₹432.19 lakh for the financial year ended March 31, 2026, driven by a 59% rise in revenue from operations to ₹18,237.81 lakh. The Board approved the audited results, which received an unmodified opinion from statutory auditors.

Ajooni Biotech confirms no encumbrance on promoter shares in FY26

Ajooni Biotech confirmed that its promoters and persons acting in concert have not created any encumbrance over shares held by them during FY26. The disclosure, signed by Managing Director Jasjot Singh, was submitted to the NSE on April 04, 2026, in compliance with SEBI regulations.

Ajooni Biotech Expands Operations with New Facility and ₹27 Crore Order Book

Ajooni Biotech has launched commercial production at a new manufacturing facility in Khanna, marking a significant operational expansion. The company has also secured cattle feed supply contracts worth ₹27.00 crores, indicating strong market demand for its products. These developments suggest enhanced production capacity and a stable revenue stream for the biotech firm.